An epigenomic approach to therapy for tamoxifen-resistant breast cancer
Qin Feng(Shanxi Medical University), Bert W. O’Malley(Baylor College of Medicine), Nicholas Mitsiades(Harvard University), Constantine S. Mitsiades(Dana-Farber Cancer Institute), C. Kent Osborne(Baylor College of Medicine), Rachel Schiff(Baylor College of Medicine), Chad J. Creighton(Baylor College of Medicine), Cristian Coarfa(Baylor College of Medicine), Agostina Nardone(AstraZeneca (Spain)), Bin He(Guiyang Medical University), Xiaoyong Fu(King University), Susan G. Hilsenbeck(Baylor College of Medicine), Lei Wang(Tang Hospital), Zheng Zhang(Chongqing Medical University), Yongcheng Song(Baylor College of Medicine), Rainer B. Lanz(Baylor College of Medicine), James E. Bradner(Novartis (China)), Martin J. Shea(Baylor College of Medicine)
Cited by 188
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
|Science|2011|1.4k